Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shravan Dave

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Alimentary Pharmacology & Therapeutics|August 26, 2021
Systematic review with network meta-analysis: comparative efficacy of pharmacologic therapies for fibrosis improvement and resolution of NASHAbdul M Majzoub, Tarek Nayfeh, Abbey Barnard, et al.
Transplantation|May 26, 2022
The Impact of Treatment of Hepatocellular Carcinoma With Immune Checkpoint Inhibitors on Pre- and Post-liver Transplant OutcomesShravan Dave, Kun Yang, Gabriel T Schnickel, et al.
Hepatology (Baltimore, Md.)|January 14, 2025
Downstaging of hepatocellular carcinoma before liver transplantation: Results from a national multicenter prospective cohort studyEdison Xu, Parissa Tabrizian, Julio Gutierrez, et al.
Alimentary Pharmacology & Therapeutics|February 14, 2025
Clinical Trial to Assess the Safety and Tolerability of Anti-IL 23 Monoclonal Antibody Guselkumab in Patients With Alcohol-Associated Liver DiseaseLuis Antonio Diaz, Sheldon Morris, Shravan Dave, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 8, 2022
Hepatocellular Carcinoma Incidence in Alcohol-Associated Cirrhosis: Systematic Review and Meta-analysisDaniel Q Huang, Darren J H Tan, Cheng Han Ng, et al.
Hepatology (Baltimore, Md.)|March 11, 2025
A prospective multicenter validation of RETREAT for posttransplantation HCC recurrence predictionP Jonathan Li, Parissa Tabrizian, Darine Daher, et al.
The Journal of Clinical Investigation|November 1, 2022
Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver diseaseNobuharu Tamaki, Noora Ahlholm, Panu K Luukkonen, et al.
Journal of Hepatology|July 12, 2024
Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysisMohammad Saeid Rezaee-Zavareh, Yee Hui Yeo, Tielong Wang, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Alimentary Pharmacology & Therapeutics|August 26, 2021
Systematic review with network meta-analysis: comparative efficacy of pharmacologic therapies for fibrosis improvement and resolution of NASHAbdul M Majzoub, Tarek Nayfeh, Abbey Barnard, et al.
Transplantation|May 26, 2022
The Impact of Treatment of Hepatocellular Carcinoma With Immune Checkpoint Inhibitors on Pre- and Post-liver Transplant OutcomesShravan Dave, Kun Yang, Gabriel T Schnickel, et al.
Hepatology (Baltimore, Md.)|January 14, 2025
Downstaging of hepatocellular carcinoma before liver transplantation: Results from a national multicenter prospective cohort studyEdison Xu, Parissa Tabrizian, Julio Gutierrez, et al.
Alimentary Pharmacology & Therapeutics|February 14, 2025
Clinical Trial to Assess the Safety and Tolerability of Anti-IL 23 Monoclonal Antibody Guselkumab in Patients With Alcohol-Associated Liver DiseaseLuis Antonio Diaz, Sheldon Morris, Shravan Dave, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 8, 2022
Hepatocellular Carcinoma Incidence in Alcohol-Associated Cirrhosis: Systematic Review and Meta-analysisDaniel Q Huang, Darren J H Tan, Cheng Han Ng, et al.
Hepatology (Baltimore, Md.)|March 11, 2025
A prospective multicenter validation of RETREAT for posttransplantation HCC recurrence predictionP Jonathan Li, Parissa Tabrizian, Darine Daher, et al.
The Journal of Clinical Investigation|November 1, 2022
Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver diseaseNobuharu Tamaki, Noora Ahlholm, Panu K Luukkonen, et al.
Journal of Hepatology|July 12, 2024
Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysisMohammad Saeid Rezaee-Zavareh, Yee Hui Yeo, Tielong Wang, et al.
Pageof 2